P. Griffiths et al., NEUROPSYCHOLOGICAL EFFECTS OF SUBSEQUENT EXPOSURE TO PHENYLALANINE INADOLESCENTS AND YOUNG-ADULTS WITH EARLY-TREATED PHENYLKETONURIA, JIDR. Journal of intellectual disability research, 39, 1995, pp. 365-372
Severe mental handicap in phenylketonuria (PKU) can be prevented if di
etary treatment is implemented at birth. Controversy remains about the
optimum age for terminating treatment. A group of adolescents and you
ng adults with PKU from the West of Scotland Register was identified w
hich had received early treatment, been well-controlled on diet, cease
d treatment at 10 years old and subsequently were hyperphenylalaninaem
ic for 3 years or more. They were given a battery of neuropsychologica
l tests and their results were compared with those of on-diet subjects
with PKU and normal controls. The findings generally supported the vi
ew that dietary cessation at age 10 is sufficient to prevent a substan
tial reduction of cognitive and motor ability, and that the central ne
rvous system is probably mature enough to withstand the toxic effects
of high blood phenylalanine by then. However, there were minor indicat
ions, in keeping with Welsh et al.'s hypothesis [:M.C. Welsh, B.F. Pen
nington, S. Ozonoff, B. Rouse & E.R.B. McCabe (1990) Neuropsychology o
f early-treated phenylketonuria: specific executive function deficits.
Child Development 61, 1697-713], that subtle intellectual deficiencie
s might arise both during and after treatment, possibly in the realm o
f frontal-executive functions.